ESCMID Conference on Corona Virus Disease (ECCVID)

Age, comorbidities may be to blame for higher COVID-19 mortality in cancer patients

Roshini Claire Anthony, 20201020180001

The increased risk of mortality among patients with cancer diagnosed with COVID-19 may be due to their older age and presence of comorbidities, according to a study presented at ECCVID 2020.

Which COVID-19 serological assays to choose?

Pearl Toh, 20201017143000

A head-to-head study comparing five serological assays for SARS-CoV-2 antibodies showed that a commercial immunoassay by Siemens and a novel ELISA* test developed by the University of Oxford could achieve the desired sensitivity and specificity without further optimization — providing reassurance for their use.

COVID-19: Fatigue common after recovery regardless of disease severity

Pearl Toh, 20201016150000

More than half of the patients who recovered from COVID-19 experienced persistent fatigue regardless of their disease severity, shows a study presented at ECCVID 2020.

COVID-19 may delay diagnosis of other diseases

Roshini Claire Anthony, 20201015180001

The COVID-19 pandemic may have caused missed or delayed diagnosis of many medical conditions, according to a UK-based retrospective study of general practice (GP) utilization.

40% of HCWs with COVID-19 are asymptomatic, risk silent transmission

Pearl Toh, 20201005150000

As high as 40 percent of the healthcare workers (HCWs) infected with COVID-19 were asymptomatic, raising concerns on silent transmission in the healthcare settings, according to a systematic review and meta-analysis released during ECCVID 2020.

COVID-19 in hospitals: Toilets, staff, public areas show contamination

Pearl Toh, 20200928150000

With a great deal of controversy surrounding the possible transmission route of SARS-CoV-2 virus, a study reveals yet another surprise worthy of caution in the hospital setting.